Samsara Therapeutics

Treating Neurodegeneration by Improving Autophagy.

Oxford, United Kingdom · Founded 2019 · $3.2M raised

Headquarters
Oxford
Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$3.2M
Last Round
$3.2M SeedJan 2019
Rounds
1

About

Samsara Therapeutics was founded in 2019 and operates from its corporate headquarters in Boston, Massachusetts, and an R&D hub in Oxford, UK. The company is pursuing therapeutics for neurodegenerative diseases through autophagy activation, running an in-house discovery platform for high-throughput, cell-based screening of small-molecule autophagy activators in disease-relevant, patient-derived iPSCs. In 2021, Apollo Health Ventures led its $25M Series A, and the company has also received endorsement and funding from patient advocacy organizations including the ALS Association, the Michael J Fox Foundation, and the CMT Research Foundation.

Summary

Samsara Therapeutics is a Biotech company based in Oxford, United Kingdom, founded in 2019. It has raised $3.2M in total across 1 round, most recently a $3.2M Seed round in Jan 2019. Investors include Apollo Health Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2019
$3.2M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Samsara Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/samsara-therapeutics"><img src="https://indexed.vc/api/badge/company/samsara-therapeutics" alt="Samsara Therapeutics on Indexed.vc" width="260" height="76" /></a>